Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (Review of TA756) [ID5115]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 26 September 2024Expected publication date: 23 October 2024